Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Thiotepa + Stupp Regimen for GBM with Ventricular/Meningeal Invasion
NCT07193654Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in glioblastoma (GBM), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Apr 2025; status: recruiting.
02
Drugs
thiotepa
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT07193654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07193654.